BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 33952592)

  • 1. Adequacy of small biopsy and cytology specimens for comprehensive genomic profiling of patients with non-small-cell lung cancer to determine eligibility for immune checkpoint inhibitor and targeted therapy.
    Faber E; Grosu H; Sabir S; San Lucas FA; Barkoh BA; Bassett RL; Luthra R; Stewart J; Roy-Chowdhuri S
    J Clin Pathol; 2022 Sep; 75(9):612-619. PubMed ID: 33952592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of lung cancer biomarkers profile for the decision of targeted therapy in EBUS-TBNA cytological samples.
    Gürün Kaya A; Çiledağ A; Erol S; Öz M; Doğan Mülazımoğlu D; Işık Ö; Özakıncı H; Çiftçi F; Şen E; Ceyhan K; Kaya A; Karnak D; Çelik G; İsmail S
    Scott Med J; 2022 Feb; 67(1):18-27. PubMed ID: 35147461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adequacy of cytology and small biopsy samples obtained with rapid onsite evaluation (ROSE) for predictive biomarker testing in non-small cell lung cancer.
    Hendry S; Mamotte L; Mesbah Ardakani N; Leslie C; Tesfai Y; Grieu-Iacopetta F; Izaac K; Singh S; Ardakani R; Thomas M; Giardina T; Robinson C; Frost F; Amanuel B
    Pathology; 2023 Dec; 55(7):917-921. PubMed ID: 37805343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis in cytological samples obtained by endobronchial or oesophageal ultrasound guided needle aspiration in non-small cell lung cancer.
    Centeno C; Serra Mitja P; Avila M; Carcereny E; Muñoz-Mármol AM; Moran T; Castellà E; Sanz-Santos J; García Olivé I; Ramirez Serrano JL; Rosell Gratacos A; Andreo García F
    Pulmonology; 2022; 28(1):28-33. PubMed ID: 32507497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adequacy of EBUS-TBNA specimen for mutation analysis of lung cancer.
    Cicek T; Ozturk A; Yılmaz A; Aktas Z; Demirag F; Akyurek N
    Clin Respir J; 2019 Feb; 13(2):92-97. PubMed ID: 30582673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suitability of endobronchial ultrasound-guided transbronchial needle aspiration samples for programmed death ligand-1 testing in non-small cell lung cancer, the Bristol experience.
    Hardy J; Bhatt N; Medford ARL
    Asia Pac J Clin Oncol; 2022 Apr; 18(2):e32-e38. PubMed ID: 33870634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical performance of endobronchial ultrasound-guided transbronchial needle aspiration for assessing programmed death ligand-1 expression in nonsmall cell lung cancer.
    Biswas A; Leon ME; Drew P; Fernandez-Bussy S; Furtado LV; Jantz MA; Mehta HJ
    Diagn Cytopathol; 2018 May; 46(5):378-383. PubMed ID: 29476608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of EBUS-TBNA for histopathological and molecular diagnostics of NSCLC-A retrospective single-center experience.
    Karadzovska-Kotevska M; Brunnström H; Kosieradzki J; Ek L; Estberg C; Staaf J; Barath S; Planck M
    PLoS One; 2022; 17(2):e0263342. PubMed ID: 35108331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adequacy of endobronchial ultrasound transbronchial needle aspiration samples in the subtyping of non-small cell lung cancer.
    Esterbrook G; Anathhanam S; Plant PK
    Lung Cancer; 2013 Apr; 80(1):30-4. PubMed ID: 23312886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Handling and standardization of EBUS needle aspiration in NSCLC patients: The value of the cell block, a monoinstitutional experience.
    Parente P; Carbonelli C; Biancofiore G; Sukthi A; Di Micco CM; Vairo M; Fuso P; Taurchini M; Graziano P
    Thorac Cancer; 2022 Sep; 13(17):2480-2488. PubMed ID: 35868633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot Study of the Performance of 19-G Needle in Endobronchial Ultrasound-guided Transbronchial Aspiration for the Diagnosis and Testing of Molecular Markers in Lung Cancer.
    Wahidi MM; Davidson K; Shofer S; Mahmood K; Cheng G; Giovacchini C; Jones C; Jug R; Pavlisko EN; Wang X; Gu L; Weimholt C; Zhou Z; Chen A
    J Bronchology Interv Pulmonol; 2021 Jul; 28(3):209-214. PubMed ID: 33273249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGFR mutational genotyping of liquid based cytology samples obtained via fine needle aspiration (FNA) at endobronchial ultrasound of non-small cell lung cancer (NSCLC).
    Reynolds JP; Tubbs RR; Minca EC; MacNamara S; Almeida FA; Ma PC; Pennell NA; Cicenia JC
    Lung Cancer; 2014 Nov; 86(2):158-63. PubMed ID: 25263855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for PD-L1 Testing in Non-small Cell Lung Cancer.
    Perrotta F; Nankivell M; Adizie JB; Maqsood U; Elshafi M; Jafri S; Lerner AD; Woolhouse I; Munavvar M; Evison M; Booton R; Baldwin DR; Janes SM; Kerr KM; Bianco A; Yarmus L; Navani N
    Chest; 2020 Sep; 158(3):1230-1239. PubMed ID: 32428509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of PD-L1, EGFR, ALK, and ROS1 Status Between Surgical Samples and Cytological Samples in Non-Small Cell Lung Carcinoma.
    Ekin Z; Nart D; Savaş P; Veral A
    Balkan Med J; 2021 Sep; 38(5):287-295. PubMed ID: 34558414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing endobronchial ultrasound for molecular analysis. How many passes are needed?
    Yarmus L; Akulian J; Gilbert C; Feller-Kopman D; Lee HJ; Zarogoulidis P; Lechtzin N; Ali SZ; Sathiyamoorthy V
    Ann Am Thorac Soc; 2013 Dec; 10(6):636-43. PubMed ID: 24079724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next-Generation Sequencing for Genotyping of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Samples in Lung Cancer.
    Xie F; Zheng X; Mao X; Zhao R; Ye J; Zhang Y; Sun J
    Ann Thorac Surg; 2019 Jul; 108(1):219-226. PubMed ID: 30885850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adequacy of core needle biopsy specimens and fine-needle aspirates for molecular testing of lung adenocarcinomas.
    Schneider F; Smith MA; Lane MC; Pantanowitz L; Dacic S; Ohori NP
    Am J Clin Pathol; 2015 Feb; 143(2):193-200; quiz 306. PubMed ID: 25596245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and reliability of evaluate PD-L1 expression determination using small biopsy specimens in non-small cell lung cancer.
    Chen M; Xu Y; Zhao J; Li J; Liu X; Zhong W; Wang M
    Thorac Cancer; 2021 Sep; 12(17):2339-2344. PubMed ID: 34291566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adequacy of lymph node transbronchial needle aspirates using convex probe endobronchial ultrasound for multiple tumor genotyping techniques in non-small-cell lung cancer.
    Folch E; Yamaguchi N; VanderLaan PA; Kocher ON; Boucher DH; Goldstein MA; Huberman MS; Kent MS; Gangadharan SP; Costa DB; Majid A
    J Thorac Oncol; 2013 Nov; 8(11):1438-1444. PubMed ID: 24128714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endobronchial Ultrasound Guided Transbronchial Needle Aspiration and PD-L1 Yields.
    Khoury LM; Sheehan KN; Mariencheck WI; Gershner KA; Maslonka M; Niehaus AG; Isom S; Bellinger CR
    Lung; 2024 Jun; 202(3):325-330. PubMed ID: 38637361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.